Suzhou Medsys Tech Co Ltd (603990) — Capital Reinvestment Ratio
Suzhou Medsys Tech Co Ltd (603990) has a Capital Reinvestment Ratio of 0.20x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥52.59 Million) in capital expenditures (CN¥10.76 Million). Check Suzhou Medsys Tech Co Ltd (603990) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suzhou Medsys Tech Co Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Suzhou Medsys Tech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Suzhou Medsys Tech Co Ltd (603990) cash conversion ratio.
Annual Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Suzhou Medsys Tech Co Ltd from 2012 to 2025. See Suzhou Medsys Tech Co Ltd (603990) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.05x | CN¥65.41 Million | CN¥68.58 Million | ▲ +115.5% |
| 2022 | 0.49x | CN¥50.51 Million | CN¥24.58 Million | ▼ -57.2% |
| 2021 | 1.14x | CN¥36.04 Million | CN¥40.99 Million | ▲ +1187.4% |
| 2020 | 0.09x | CN¥100.48 Million | CN¥8.88 Million | ▼ -84.9% |
| 2019 | 0.58x | CN¥22.04 Million | CN¥12.89 Million | ▲ +71.3% |
| 2018 | 0.34x | CN¥48.67 Million | CN¥16.62 Million | ▼ -60.3% |
| 2016 | 0.86x | CN¥32.56 Million | CN¥28.01 Million | ▼ -59.6% |
| 2015 | 2.13x | CN¥37.54 Million | CN¥79.94 Million | ▲ +38.9% |
| 2014 | 1.53x | CN¥40.82 Million | CN¥62.59 Million | ▲ +139.5% |
| 2013 | 0.64x | CN¥32.84 Million | CN¥21.03 Million | ▲ +193.0% |
| 2012 | 0.22x | CN¥10.83 Million | CN¥2.37 Million | — |